[go: up one dir, main page]

WO2008149088A3 - Melanoma assay and antigens - Google Patents

Melanoma assay and antigens Download PDF

Info

Publication number
WO2008149088A3
WO2008149088A3 PCT/GB2008/001907 GB2008001907W WO2008149088A3 WO 2008149088 A3 WO2008149088 A3 WO 2008149088A3 GB 2008001907 W GB2008001907 W GB 2008001907W WO 2008149088 A3 WO2008149088 A3 WO 2008149088A3
Authority
WO
WIPO (PCT)
Prior art keywords
melanoma
antigens
fingerprint
identifying
relates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/GB2008/001907
Other languages
French (fr)
Other versions
WO2008149088A8 (en
WO2008149088A2 (en
Inventor
Robert Charles Rees
Graham Roy Ball
Balwir Matharoo-Ball
Colin Creaser
Amanda Miles
Lee Lancashire
Selma Ugurel
Dirk Schadendorf
Christophe Lemetre
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Deutsches Krebsforschungszentrum DKFZ
Nottingham Trent University
Original Assignee
Deutsches Krebsforschungszentrum DKFZ
Nottingham Trent University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0710636A external-priority patent/GB0710636D0/en
Priority claimed from GB0710768A external-priority patent/GB0710768D0/en
Application filed by Deutsches Krebsforschungszentrum DKFZ, Nottingham Trent University filed Critical Deutsches Krebsforschungszentrum DKFZ
Publication of WO2008149088A2 publication Critical patent/WO2008149088A2/en
Publication of WO2008149088A3 publication Critical patent/WO2008149088A3/en
Publication of WO2008149088A8 publication Critical patent/WO2008149088A8/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/5743—Specifically defined cancers of skin, e.g. melanoma
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848—Methods of protein analysis involving mass spectrometry
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4728—Details alpha-Glycoproteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Food Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hospice & Palliative Care (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)

Abstract

The invention relates to a mass spectrometry melanoma fingerprint for identifying the presence of a melanoma and/or for identifying the stage of a melanoma. The invention also relates the use of a fingerprint to identify the presence of a melanoma and/or for identifying the stage of a melanoma. Furthermore, the invention relates to a computer comprising the fingerprint.
PCT/GB2008/001907 2007-06-04 2008-06-04 Melanoma assay and antigens Ceased WO2008149088A2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0710636A GB0710636D0 (en) 2007-06-04 2007-06-04 Method of indentifiying biomarkers
GB0710636.2 2007-06-04
GB0710768A GB0710768D0 (en) 2007-06-05 2007-06-05 Method of identifying biomarkers
GB0710768.3 2007-06-05

Publications (3)

Publication Number Publication Date
WO2008149088A2 WO2008149088A2 (en) 2008-12-11
WO2008149088A3 true WO2008149088A3 (en) 2009-03-05
WO2008149088A8 WO2008149088A8 (en) 2009-07-16

Family

ID=39735427

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2008/001907 Ceased WO2008149088A2 (en) 2007-06-04 2008-06-04 Melanoma assay and antigens

Country Status (1)

Country Link
WO (1) WO2008149088A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104833803B (en) * 2015-04-27 2017-01-04 深圳市检验检疫科学研究院 The multiple detection method of a kind of bean pathogenetic bacteria and data base
AU2018324195B2 (en) 2017-09-01 2024-12-12 Venn Biosciences Corporation Identification and use of glycopeptides as biomarkers for diagnosis and treatment monitoring
EP4305427A4 (en) * 2021-03-08 2025-07-23 Venn Biosciences Corp BIOMARKERS FOR DETERMINING AN IMMUNO-ONCOLOGICAL RESPONSE
WO2024248604A2 (en) * 2023-05-29 2024-12-05 National Taiwan University Method of establishing cancer screening module, using method and platform thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006074430A2 (en) * 2005-01-07 2006-07-13 The Johins Hopkins University Biomarkers for melanoma

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006074430A2 (en) * 2005-01-07 2006-07-13 The Johins Hopkins University Biomarkers for melanoma

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
BALWIR MATHEROO-BALL ET. AL: "Diagnostic biomarkers differentiating metastatic melanoma patients from healthy controls identified by an integrated MALDI-TOF mass spectrometry/bioinformatic approach", PROTEOMICS CLIN. APPL., vol. 1, 2007, pages 605 - 620, XP002496509 *
CAPUTO EMILIA ET AL: "Peptide profiling in epithelial tumor plasma by the emerging proteomic techniques.", JOURNAL OF CHROMATOGRAPHY. B, ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES 5 MAY 2005, vol. 819, no. 1, 5 May 2005 (2005-05-05), pages 59 - 66, XP002496511, ISSN: 1570-0232 *
HIGAI KOJI ET AL: "Altered glycosylation of alpha1-acid glycoprotein in patients with inflammation and diabetes mellitus.", CLINICA CHIMICA ACTA; INTERNATIONAL JOURNAL OF CLINICAL CHEMISTRY MAR 2003, vol. 329, no. 1-2, March 2003 (2003-03-01), pages 117 - 125, XP002496508, ISSN: 0009-8981 *
RICHTER J ET AL: "SOME IMMUNOLOGICAL FINDINGS IN MALIGNANT MELANOMA", CESKOSLOVENSKA DERMATOLOGIE, vol. 55, no. 1, 1980, pages 12 - 18, XP008096545, ISSN: 0009-0514 *

Also Published As

Publication number Publication date
WO2008149088A8 (en) 2009-07-16
WO2008149088A2 (en) 2008-12-11

Similar Documents

Publication Publication Date Title
WO2009014787A3 (en) Multianalyte assay
WO2006104989A3 (en) Altered antibody fc regions and uses thereof
WO2009097979A3 (en) Security element
WO2007136893A3 (en) Anti-fgf19 antibodies and methods using same
WO2011008349A3 (en) Methods of identifying infectious disease and assays for identifying infectious disease
WO2008048970A8 (en) Synthetic antibodies
WO2007133290A8 (en) Anti-ox40l antibodies and methods using same
WO2008097908A3 (en) Methods of diagnosing and prognosing lung cancer
WO2009140039A3 (en) Synthetic antibodies
WO2007130697A3 (en) Anti-ephb4 antibodies and methods using same
WO2008130887A8 (en) Biomarkers for follicular thyroid carcinoma and methods of of use
WO2010011107A3 (en) Portable display device
WO2007047408A3 (en) Promac signature application
WO2009004593A3 (en) Processes for the preparation of epinephrine
WO2012075069A3 (en) Signatures and determinants associated with cancer and methods of use thereof
WO2007127506A3 (en) Anti-ephrinb2 antibodies and methods using same
WO2005114452A3 (en) Service oriented architecture
WO2009052221A3 (en) Methods for extracting platelets and compositions obtained therefrom
WO2009082445A3 (en) Novel devices for the detection of the presence and/or activity of proteases in biological samples
WO2009007649A3 (en) Device and method for identifying and determining blood groups
WO2009120183A3 (en) System for the detection of a biological pathogen and use thereof
WO2008043543A3 (en) Nucleic acid beacons for fluorescent in-situ hybridisation and chip technology
WO2007121147A3 (en) Disheveled pdz modulators
WO2010036336A3 (en) Interest manager
WO2008149088A3 (en) Melanoma assay and antigens

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08762259

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08762259

Country of ref document: EP

Kind code of ref document: A2